CLVR (Clever Leaves Holdings) Accumulated Depreciation: $-8.79 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLVR Clever Leaves Holdings Inc CLVR
12 GF Score
Price $0.00
View Full Analysis

What is Clever Leaves Holdings Accumulated Depreciation?

Clever Leaves Holdings CLVR 12 Accumulated Depreciation is $-8.79 Mil as of Dec. 2023. GuruFocus rates CLVR with a GF Score™ of 12/100.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Clever Leaves Holdings's quarterly accumulated depreciation increased from Jun. 2023 ($-7.99 Mil) to Sep. 2023 ($-8.39 Mil) and increased from Sep. 2023 ($-8.39 Mil) to Dec. 2023 ($-8.79 Mil).

Clever Leaves Holdings's annual accumulated depreciation increased from Dec. 2021 ($-5.70 Mil) to Dec. 2022 ($-7.12 Mil) and increased from Dec. 2022 ($-7.12 Mil) to Dec. 2023 ($-8.79 Mil).

Clever Leaves Holdings Accumulated Depreciation Related Terms

Clever Leaves Holdings Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Clever Leaves Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clever Leaves Holdings Accumulated Depreciation Chart

Clever Leaves Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
-1.00 -3.36 -5.70 -7.12 -8.79

Clever Leaves Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.12 -7.53 -7.99 -8.39 -8.79
CLVR
12GF Score
Clever Leaves Holdings Inc CLVR
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clever Leaves Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-8.79 Mil mean?
Clever Leaves Holdings (CLVR) has a Accumulated Depreciation of $-8.79 Mil as of Dec. 2023. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Clever Leaves Holdings and its competitors.
Is Clever Leaves Holdings' Accumulated Depreciation too high?
Clever Leaves Holdings' current Accumulated Depreciation is $-8.79 Mil. Overall, Clever Leaves Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Clever Leaves Holdings' Accumulated Depreciation compare to CNNC and CLSH?
Clever Leaves Holdings' Accumulated Depreciation of $-8.79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Clever Leaves Holdings and its competitors. Clever Leaves Holdings's current Accumulated Depreciation is $-8.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clever Leaves Holdings stock overvalued right now?
Clever Leaves Holdings (CLVR) has a current Accumulated Depreciation of $-8.79 Mil. The current Accumulated Depreciation is $-8.79 Mil. Clever Leaves Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Clever Leaves Holdings (CLVR), the current Accumulated Depreciation is $-8.79 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clever Leaves Holdings Business Description

Address Bodega 19-B Parque Industrial Tibitoc P.H, Tocancipa, Cundinamarca, Bogota, COL
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namely, the Cannabinoid segment which is comprised of the company's cultivation, extraction, and commercialization of cannabinoid products; and the Non-Cannabinoid operating segment which generates maximum revenue and is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.
12GF Score

Get the complete analysis for CLVR

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price